English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Untangling extracellular proteasome-osteopontin circuit dynamics in multiple sclerosis.

MPS-Authors
/persons/resource/persons208298

Liepe,  J.
Research Group of Quantitative and System Biology, MPI for Biophysical Chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

3035143.pdf
(Publisher version), 4MB

Supplementary Material (public)

3035143_Suppl.pdf
(Supplementary material), 567KB

Citation

Dianzani, C., Vecchio, D., Clemente, N., Chiocchetti, A., Boneschi, F. M., Galimberti, D., et al. (2019). Untangling extracellular proteasome-osteopontin circuit dynamics in multiple sclerosis. Cells, 8(3): 262. doi:10.3390/cells8030262.


Cite as: https://hdl.handle.net/21.11116/0000-0003-3A9B-E
Abstract
The function of proteasomes in extracellular space is still largely unknown. The extracellular proteasome-osteopontin circuit has recently been hypothesized to be part of the inflammatory machinery regulating relapse/remission phase alternation in multiple sclerosis. However, it is still unclear what dynamics there are between the different elements of the circuit, what the role of proteasome isoforms is, and whether these inflammatory circuit dynamics are associated with the clinical severity of multiple sclerosis. To shed light on these aspects of this novel inflammatory circuit, we integrated in vitro proteasome isoform data, cell chemotaxis cell culture data, and clinical data of multiple sclerosis cohorts in a coherent computational inference framework. Thereby, we modeled extracellular osteopontin-proteasome circuit dynamics during relapse/remission alternation in multiple sclerosis. Applying this computational framework to a longitudinal study on single multiple sclerosis patients suggests a complex interaction between extracellular proteasome isoforms and osteopontin with potential clinical implications.